drugset / Trial / NCT01200251

Study of Bimatoprost Gel on Eyelash Growth

NCT01200251

Phase 3 Completed 20 enrolled Duke University
RandomizedCrossoverSingle-blindTreatment

Summary

A internally controlled, single-blinded, randomized controlled trial to investigate the use of Bimatoprost eyelash gel on eyelash growth and appearance in breast cancer patients who suffer from madarosis (loss of eyelashes) due to the side effects of chemotherapy. IND and IRB approval have been obtained.

Timeline

Start
2007-02
Primary completion
2007-09
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bimatoprost Other / unclassified 0.03 % Topical